Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus bupivacaine + magnesium sulphate for TAP block after abdominal gynecological surgery
PACTR202208499106275Phase 0Not yet recruiting
- Sponsor
- Olatunde Towobola
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of bupivacaine and magnesium sulfate in postoperative pain (2 arms), sponsored by Olatunde Towobola. Primary endpoint: Pain scores following TAP block. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
bupivacainemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202208499106275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208499106275.